Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArgo Blockchai. Regulatory News (ARB)

  • There is currently no data for ARB

Board Appointment

21 Jul 2020 07:00

RNS Number : 5426T
Argo Blockchain PLC
21 July 2020
 

PRESS RELEASE

21 July 2020

ARGO BLOCKCHAIN

('Argo' or 'the Company')

Board Appointment

 

Argo, the leading publicly traded cryptocurrency miner (LSE:ARB), is pleased to announce the appointment of Dr. Marco D'Attanasio to the Company's board of directors with immediate effect. Dr D'Attanasio has been appointed as an independent non-executive director and brings over 20 years experience in international capital markets, fund management as well as entrepreneurship in the technology sector. He holds a PhD from the University of Parma in Italy in theoretical and mathematical physics.

Dr. D'Attanasio is currently the Chief Investment Officer at Hadron Capital, an investment management firm he co-founded which is based in London. Hadron Capital LLP currently holds 13,548,000 ordinary shares in the Company. Prior to co-founding Hadron Capital, Dr. D'Attanasio served as a Managing Director at the Royal Bank of Canada in London and was responsible for the Europe and Asia Relative Value Group, a 10-man proprietary trading unit based in London and Hong Kong.

Peter Wall, chief executive of Argo, said: "We are excited to welcome Marco to the board as an independent director after a rigorous selection process in which he immediately stood out as an exceptional candidate. His broad experience in corporate finance and capital markets will benefit Argo as the company progresses its strategic objective to become one of the largest publicly traded cryptocurrency mining companies."

Marco D'Attanasio, said: "I am delighted to be joining the board of Argo which has positioned itself as one of most efficient publicly-listed cryptominers in the world. I look forward to working with the board and the executive team to build on the company's strong foundations."

The Company would also like to take this opportunity to thank Timothy Le Druillenec, whose departure as a non-executive director took place at the close of the AGM, as announced in the Notice of the Annual General Meeting.

There are no details to be disclosed under paragraph 9.6.13 (2) to (6) of the Listing Rules.

 

For further information please contact:

Argo Blockchain

Peter Wall

Chief Executive

via Tancredi +44 203 434 2334

 

 

 

Mirabaud

Corporate Broker

Peter Krens

+44 203 167 7221

Tancredi Communication

Media Relations

Salamander Davoudi

salamander@tancredigroup.com

 Emma Valgimigli

emma@tancredigroup.com

+44 7957 549 906

 

 

+44 7727 180 873

 

 

 

About Argo:

Argo Blockchain plc is a global leader in cryptocurrency mining with one of the largest and most efficient operations powered by clean energy. The Company is headquartered in London, UK and its shares are listed on the Main Market of the London Stock Exchange under the ticker: ARB.

 

argoblockchain.com

 

See Argo's largest facility in Quebec:

https://youtu.be/LDWWaZ75Zbk

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAPPUQPMUPUGQU
Date   Source Headline
5th Aug 20227:00 amRNSJuly 2022 Operational Update
7th Jul 20227:00 amRNSJune 2022 Operational Update
30th Jun 20227:00 amRNSTotal Voting Rights
29th Jun 20221:00 pmRNSResult of Annual General Meeting
27th Jun 202211:30 amRNSQ&A following the Annual General Meeting
15th Jun 202211:05 amRNSSecond Price Monitoring Extn
15th Jun 202211:00 amRNSPrice Monitoring Extension
14th Jun 20227:00 amRNSVoting at the Annual General Meeting
9th Jun 20227:00 amRNSAllotment of New Shares
7th Jun 20227:00 amRNSMay 2022 Operational Update
6th Jun 20222:00 pmRNSNotice of Annual General Meeting
31st May 20227:00 amRNSShare Capital and Total Voting Rights
25th May 20227:00 amRNSPDMR Dealings & Option Grants
19th May 20224:40 pmRNSSecond Price Monitoring Extn
19th May 20224:35 pmRNSPrice Monitoring Extension
18th May 20224:35 pmRNSPrice Monitoring Extension
18th May 20227:00 amRNS1st Quarter Results 2022
16th May 20227:00 amRNSNotice - Q1 2022 Results and Investor Presentation
12th May 202211:05 amRNSSecond Price Monitoring Extn
12th May 202211:00 amRNSPrice Monitoring Extension
12th May 20229:05 amRNSSecond Price Monitoring Extn
12th May 20229:00 amRNSPrice Monitoring Extension
12th May 20227:00 amRNSPosting of Annual Report
9th May 20227:00 amRNSApril 2022 Operational Update
5th May 20224:41 pmRNSSecond Price Monitoring Extn
5th May 20224:35 pmRNSPrice Monitoring Extension
5th May 20229:05 amRNSSecond Price Monitoring Extn
5th May 20229:00 amRNSPrice Monitoring Extension
5th May 20227:00 amRNSEnergization & Official Opening of Helios Facility
4th May 20227:00 amRNSAdditional Equipment Financing from NYDIG
28th Apr 20229:06 amRNSSecond Price Monitoring Extn
28th Apr 20229:00 amRNSPrice Monitoring Extension
28th Apr 20227:00 amRNS2021 Full Year Results
25th Apr 20227:00 amRNSNotice of 2021 Full Year Results
8th Apr 20227:00 amRNSMarch 2022 Operational Update
14th Mar 20227:00 amRNSFleet Swap Agreement with Core Scientific
11th Mar 20227:00 amRNSInvestor Conferences
10th Mar 20227:00 amRNSEquipment Financing Agreement with NYDIG
9th Mar 202211:05 amRNSSecond Price Monitoring Extn
9th Mar 202211:00 amRNSPrice Monitoring Extension
7th Mar 20227:00 amRNSFebruary 2022 Operational Update
28th Feb 20224:42 pmRNSSecond Price Monitoring Extn
28th Feb 20224:36 pmRNSPrice Monitoring Extension
24th Feb 20227:00 amRNSBoard Announcement
17th Feb 20224:36 pmRNSPrice Monitoring Extension
7th Feb 20227:00 amRNSJanuary 2022 Operational Update
19th Jan 20227:00 amRNSUpdate on Argo Labs
7th Jan 20225:48 pmRNSDecember 2021 Operational Update - Replacement
7th Jan 20229:00 amRNSPrice Monitoring Extension
7th Jan 20227:00 amRNSDecember Operational Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.